| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.9 |